You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 298 No. 5, August 1, 2007 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Correction
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Pulmonary Diseases, Other
 •Statistics and Research Methods
 •Oncology
 •Lung Cancer
 •Angiology
 •Computed Tomography
 •Alert me on articles by topic

Computed Tomography Screening for Lung Cancer

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: We feel obliged to comment on the study of CT screening and lung cancer outcome by Dr Bach and colleagues1 because we are responsible for the conduct and follow-up of the Italian trial carried out by the European Institute of Oncology, from which data were used in this study.

Their analysis is based on the unproved belief that lung cancers can be divided into 2 distinct groups of indolent and aggressive tumors, while lung cancer aggressiveness is largely correlated, on a continuous scale, to the size of the tumor.2 Aggregating stage III with stage IV tumors also constitutes an arbitrary oversimplification since patients with stage III tumors and minimal nodal invasion are amenable to curative treatment.3

In addition, the prediction model derives from data from the Beta-Carotene and Retinol Efficacy Trial (CARET), which was conducted in the United States from 1989-1994. Since then, cardiovascular mortality, which constitutes . . . [Full Text of this Article]

Lorenzo Spaggiari, PhD; Giulia Veronesi, MD
giulia.veronesi@ieo.it

Massimo Bellomi, PhD; Patrick Maisonneuve, Eng
European Institute of Oncology
Milan, Italy


RELATED LETTERS

Computed Tomography Screening for Lung Cancer
Ambarish Gopal and Matthew J. Budoff
JAMA. 2007;298(5):513.
EXTRACT | FULL TEXT  

Computed Tomography Screening for Lung Cancer
Christine D. Berg and Denise R. Aberle
JAMA. 2007;298(5):513-514.
EXTRACT | FULL TEXT  

Computed Tomography Screening for Lung Cancer
Claudia I. Henschke, David Yankelevitz, James P. Smith, and Olli S. Miettinen
JAMA. 2007;298(5):514-515.
EXTRACT | FULL TEXT  

Computed Tomography Screening for Lung Cancer—Reply
Peter B. Bach, James R. Jett, Ugo Pastorino, Melvyn S. Tockman, Stephen J. Swensen, and Colin B. Begg
JAMA. 2007;298(5):515-516.
EXTRACT | FULL TEXT  

RELATED ARTICLE

Computed Tomography Screening and Lung Cancer Outcomes
Peter B. Bach, James R. Jett, Ugo Pastorino, Melvyn S. Tockman, Stephen J. Swensen, and Colin B. Begg
JAMA. 2007;297(9):953-961.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Computed Tomography Screening for Lung Cancer
Bach
Clin. Cancer Res. 2008;14:2511-2511.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.